Hosp. of the Univ. of Pennsylvania CRS (6201)

Philadelphia, Pennsylvania 19104

0 studies enrolling now · 14 studies all time

What they study most

HIV Infections, HIV-1 Infection, HIV-1-infection, Hepatitis C, Liver Diseases, Tuberculosis

Studies at this site

• PREPARE (A5361s) Ancillary Study of REPRIEVE (A5332) — Completed
• Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection — Completed
• Pharmacokinetic Study to Evaluate Double-Dose Levonorgestrel Emergency Contraception in Combination With Efavirenz-Based Antiretroviral Therapy or Rifampicin-Containing Anti-Tuberculosis Therapy — Completed
• FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir — Completed
• Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells — Completed
• High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART — Completed
• Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression — Completed
• Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults — Completed
• Sevelamer for Reducing Endotoxemia and Immune Activation — Completed
• Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV — Stopped early
• Rifaximin as a Modulator of Microbial Translocation and Immune Activation — Completed
• Sitagliptin for Reducing Inflammation and Immune Activation — Completed
• Dolutegravir Plus Lamivudine Dual Therapy in Treatment Naïve HIV-1 Patients — Completed
• Chloroquine for Reducing Immune Activation in HIV- Infected Individuals — Completed